InvestorsHub Logo
Followers 11
Posts 600
Boards Moderated 0
Alias Born 12/13/2016

Re: ChuckG1 post# 2231

Monday, 08/07/2017 5:48:49 PM

Monday, August 07, 2017 5:48:49 PM

Post# of 7474
DD Regarding CNBX being held down: This is the what I posted back in May regarding CNBX price being torpedoed by a number of articles that obviously all started by the same person and then were disseminated on different sites under different author names.

The post below includes an email from the OTC Board where CNBX is traded.

Fear not, CNBX will come raging back!!! But we have to get through people like this working to control its price:

jim992  
Wednesday, 05/17/17 02:24:21 AM
Re: sinky post# 1558

Post # of 2231 

Alan Brochstein wrote the BS article "Cannabics Pharmaceuticals Triggers Regulatory Scrutiny After Parabolic Spike" that caused CNBX to fall from $ 7+.

When I contacted the OTC board about his claims of "scrutiny" and provided them his article, they replied with the following denouncement that there had been no "scrutiny" of CNBX and stated that they believed Brochstein's article was a statement from CNBX, which it obviously was not.

Here is their reply regarding his article and their views of Brochstein speaking with any knowledge. Keep in mind the article title above regarding "Regulatory Scrutiny":

"Thank you for your email. Please note that OTC Markets has never announced a review of any nature regarding the company; and for further clarification, OTC Markets Group is not a regulatory agency. The links you included reference the company’s press release disseminated on February 23, 2017.

Please let us know if you have any additional questions.

Sincerely,

Gareth Colglazier
OTC Markets Group
100 M Street SE, Suite 220 / Washington, DC 20003
Office: (212) 896-4458
Email: gareth@otcmarkets.com"

So Brochstein claimed "regulatory scrutiny" of CNBX where there was none, and when I included his article in my email to OTC, (full article linked below), they thought it was from CNBX. Anyone that read the article would know CNBX did not put this out.

In short, Brochstein has already proven in the last 90 days to be a person that likes to claim knowledge he does not have, claim "regulatory scrutiny" where there has been none, and when his articles are provided to the OTC Board, they denounce him as probably a nut working to stir up CNBX or MM news and nothing more.

He has cost us enough. Do not give someone that OTC has gone on record as not having the knowledge he claims to have any more credence than he has already falsely given himself.

Jim

https://www.newcannabisventures.com/cannabics-pharmaceuticals-triggers-regulatory-scrutiny-after-parabolic-spike/